Search results for "Psoriasis"

showing 10 items of 193 documents

Knochenbefunde bei Psoriasis

1978

Unter 40 mit der Ganzkorperscintigraphie (Technetium-Diphosphonat) untersuchten Psoriatikern fanden sich bei 3 Patientinnen diffuse und umschriebene pathologisch gesteigerte Nuklidanreicherungen im Schadelskelet. Diese gelenkfernen Proliferationszeichen im Knochenbereich weisen ebenso wie der gegenuber dem Gelenkscan haufiger positive Knochenscan auf eine Fruhbeteiligung des knochernen Skelets bei Psoriasis hin.

medicine.medical_specialtybusiness.industryPsoriasismedicinePsoriasis arthritisDermatologyGeneral Medicinemedicine.diseasebusinessDermatologyArchives of Dermatological Research
researchProduct

Severe nail psoriasis with a rapid response to acitretin

2009

medicine.medical_specialtybusiness.industrymedicineDermatologybusinessNail psoriasisDermatologyRapid responseAcitretinmedicine.drugClinical and Experimental Dermatology
researchProduct

Ustekinumab therapy changes the transcriptional activity pattern of TGF-β1–3 genes

2019

Introduction One of the examples of genes whose expression can be altered by the action of ustekinumab is TGF-β. It is a pleiotropic cytokine whose activity affects psoriatic changes and the state of homeostasis of the whole organism. Aim To evaluate the effect of ustekinumab on the transcriptional activity of TGF-b family genes in patients with psoriatic arthritis and to check whether the results obtained can be helpful in monitoring the progress of treatment. Material and methods From total PBMCs obtained from peripheral blood of 14 patients with psoriatic arthritis, total RNA was isolated. The expression level of the TGF-β1, TGF-β2 and TGF-β3 genes was determined by RT-qPCR in real time.…

molecular markerMessenger RNAOriginal Paperbusiness.industrymedicine.medical_treatmentRNApsoriasis arthritisDermatologyPharmacologymedicine.diseasePeripheral blood mononuclear cellRC31-1245ustekinumabPsoriatic arthritisCytokineRL1-803UstekinumabmedicineImmunology and Allergytgfβ1-3businessGeneInternal medicinemedicine.drugTransforming growth factorAdvances in Dermatology and Allergology
researchProduct

Traditional and new types of spondarthritis with special consideration of spondylodiscitis

1990

In rheumatology the so-called "seronegative spondarthritis" is a group of diseases characterized by the presence of HLA-B 27. This group includes the typical ankylosing spondylitis as well as atypical spondylopathies such as those occurring in psoriasis, Reiter's disease and chronic inflammatory enteropathies, which attack mainly the spine and secondarily the peripheral joints. In some severe cases, non-infectious, sterile spondylodiscitis was observed. These can lead to instability and fracture, followed by pseudarthrosis of the involved segment of the spine. In contrast to these traditional spondarthritides three new types are marked by the lack of HLA-B 27. 1) "Spondarthritis hyperostoti…

musculoskeletal diseasesSpondylodiscitismedicine.medical_specialtyDiscitisDiseaseRenal DialysisInternal medicinePsoriasisAcne VulgarismedicineHumansPsoriasisSpondylitisAnkylosing spondylitisAcne fulminansbusiness.industrySyndromeGeneral Medicinemedicine.diseaseRheumatologySurgeryPseudarthrosisSurgeryNeurology (clinical)businessSpondylitisNeurosurgical Review
researchProduct

Bērnības pieredzes saikne ar personības īpatnībām psoriāzes pacientiem

2020

Vairāki psihiskie traucējumi ir saistīti ar psoriāzi, etiopatoģenēze ir daudzveidīga. Dažas psihiskas blakusslimības var rasties hroniskas ādas slimības psihosociālās ietekmes rezultātā. No otras puses, psoriāzi var uzturēt un saasināt pacienta esošais psihiskais stāvoklis, tādējādi veidojot apburto loku. Bērnības pieredze nosaka to, kā veidosies cilvēka personības stiprās un vājās puses, tā ietekmē reakciju uz saslimšanu, tajā skaitā- psoriāzi. Kā aleksitīmija, tā personības traucējumi var ietekmēt to, kā pacients uztver saslimšanu, kā ar to sadzīvo un ārstē.Latvijā nav pētīta psoriāzes saistība ar bērnības pieredzi, personības traucējumiem un aleksitīmiju. Pētījuma hipotēze: psoriāzes pac…

personality states (disorders)psoriāzepersonības īpatnības (traucējumi)psoriasisaleksitīmijaMedicīna
researchProduct

The prevalence of the obesity in patients with moderate to severe psoriasis in Sicily populations

2009

psoriasis obesitySettore MED/35 - Malattie Cutanee E Veneree
researchProduct

Lack of reactivation of tuberculosis in patients with psoriasis treated with secukinumab in a real-world setting of latent tuberculosis infection

2022

Background Some biologics for psoriasis, especially anti-tumor necrosis factor (TNF)-alpha therapies, may re-activate latent tuberculosis (TBC) infection with consequent morbidity and mortality. However, there is a low reported incidence of conversion to positive TBC status among patients with psoriasis treated with second-generation biologic therapies, particularly anti-interleukin (IL)-17 therapies such as secukinumab. Objectives To evaluate the safety profile of secukinumab in psoriasis patients with latent TBC infection. Methods Real-life data were collected by retrospective chart review on patients with moderate-to-severe psoriasis who showed positivity for TBC screening at baseline an…

reactivationBiologicpsoriasis.latent tuberculosis infectionsecukinumabchemoprophylaxisDermatologyBiologicsBiologics; chemoprophylaxis; latent tuberculosis infection; psoriasis; reactivation; secukinumab.Antibodies Monoclonal HumanizedSeverity of Illness IndexTreatment OutcomeLatent TuberculosisIsoniazidHumansPsoriasisTuberculosisRifampinchemoprophylaxiRetrospective Studiespsoriasi
researchProduct

Retinal Vascular Assessment in Psoriasis: A Multicenter Study

2021

PurposeTo investigate the vascular status of the macula in psoriasis patients without history of ocular inflammation by Optical Coherence Tomography Angiography (OCTA).MethodsThis prospective cross-sectional multicenter study included 55 psoriasis patients and 55 control healthy subjects. A complete eye examination and 6 mm × 6 mm OCTA imaging were performed. Retinal vascular status was evaluated by analyzing vascular density (VD) of superficial vascular plexus (superficial wVD) and deep vascular plexuses (deep wVD) in a 6 mm × 6 mm area and in foveal (superficial fVD and deep fVD) and parafoveal sectors (superficial pVD and deep pVD). In addition, foveal thickness (FT) and foveal avascular…

retinaIntraocular pressuremedicine.medical_specialtyvascular changesgenetic structuresmacula; optical coherence tomography angiography; psoriasis; retina; vascular changesoptical coherence tomography angiographylcsh:RC321-571030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundPsoriatic arthritis0302 clinical medicineOphthalmologyPsoriasisMedicinemaculalcsh:Neurosciences. Biological psychiatry. NeuropsychiatrypsoriasiOriginal ResearchRetinamedicine.diagnostic_testbusiness.industryGeneral NeuroscienceRetinalpsoriasisOptical coherence tomography angiographymedicine.diseaseeye diseasesmedicine.anatomical_structurechemistryMulticenter studyEye examination030221 ophthalmology & optometrysense organsbusinessNeuroscienceFrontiers in Neuroscience
researchProduct

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders.

2021

The past decades have yielded major therapeutic advances in many autoimmune conditions – such as multiple sclerosis (MS) – and thus ushered in a new era of more targeted and increasingly potent immunotherapies. Yet this growing arsenal of therapeutic immune interventions has also rendered therapy much more challenging for the attending physician, especially when treating patients with more than one autoimmune condition. Importantly, some therapeutic strategies are either approved for several autoimmune disorders or may be repurposed for other conditions, therefore opening new curative possibilities in related fields. In this article, we especially focus on frequent and therapeutically rele…

rheumatoid arthritismedicine.medical_specialtymedicine.medical_treatmentPsychological interventionReviewmultiple sclerosisInflammatory bowel diseaseinflammatory bowel diseasePsoriasismedicineRC346-429Intensive care medicinePharmacologybusiness.industryMultiple sclerosisInflammatory Bowel DiseasesImmunotherapypsoriasismedicine.diseaseNeurologyRheumatoid arthritisNeurology. Diseases of the nervous systemNeurology (clinical)immunotherapyAutoimmune conditionbusinessTherapeutic advances in neurological disorders
researchProduct

Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in De…

2020

Background: Registry studies broadly describing the safety of systemic drugs in psoriasis are needed. Objective: To describe the safety findings of the systemic drugs acitretin, adalimumab, apremilast, cyclosporine, etanercept, infliximab, methotrexate, secukinumab, and ustekinumab used for the treatment of moderate to severe psoriasis in patients included in the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry. Methods: The incidence rate ratio (IRR) and adjusted IRR (including propensity scores) of identified adverse events for each drug, using methotrexate as reference, were determined by means of a prospective cohort. Results: O…

safetyAdultMalemedicine.medical_specialtyTime Factorsbiologic agentsprospective cohortlong-term follow-upDermatologyimmunosuppressive agentsanti-inflammatory agentsCohort Studies030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicinePsoriasisUstekinumabmedicineAdalimumabHumansPsoriasisRegistriesAdverse effectProspective cohort studyAgedbusiness.industryregistriespsoriasis/drug therapyanti-TNFMiddle Agedmedicine.diseaseInfliximabBiological TherapySpain030220 oncology & carcinogenesispharmacovigilanceadverse effectsSecukinumabFemaleApremilastbusinessmedicine.drugJournal of the American Academy of Dermatology
researchProduct